Preparation and evaluation of 186 / 188 Re -

نویسندگان

  • Kazuma Ogawa
  • Hidekazu Kawashima
  • Seigo Kinuya
  • Kazuhiro Shiba
  • Masahisa Onoguchi
  • Hiroyuki Kimura
  • Kazuyuki Hashimoto
  • Akira Odani
  • Hideo Saji
چکیده

Objective: Rhenium is one of the most valuable elements for internal radiotherapy because Re and Re have favorable physical characteristics. However, there are problems when proteins such as antibodies are used as carriers of Re. Labeling methods that use bifunctional chelating agents such as MAG3 require the conjugation of the Re complex to protein after radiolabeling with the bifunctional chelating agent. These processes are complicated. Therefore, we planned the preparation by a simple method and evaluation of a stable Re-labeled antibody. For this purpose, we selected Re(I) tricarbonyl complex as a chelating site. In this study, A7 (an IgG1 murine monoclonal antibody) was used as a model protein. Re-labeled A7 was prepared by directly reacting a Re(I) tricarbonyl precursor, [Re(CO)3(H2O)3], with A7. We then compared the biodistribution of Re-labeled A7 in tumor-bearing mice with I-labeled A7. Methods: For labeling A7, [Re(CO)3(H2O)3] was prepared according to a published procedure. Re-labeled A7 (Re-(CO)3-A7) was prepared by reacting [Re(CO)3(H2O)3] with A7 at 43oC for 2 hours. Ogawa et al. Page 4/29 Biodistribution experiments were performed by the intravenous administration of Re-(CO)3-A7 solution into tumor-bearing mice. Results: Re-(CO)3-A7 and Re-(CO)3-A7 were prepared with radiochemical yields of 23% and 28%, respectively. After purification by a PD-10 column, Re-(CO)3-A7 showed a radiochemical purity of over 95%. In biodistribution experiments, 13.1% and 13.2% of the injected dose/g of Re-(CO)3-A7 and Re-(CO)3-A7, respectively, accumulated in the tumor 24 hours postinjection, and the tumor-to-blood ratios were over 2.0 at the same timepoint. Meanwhile, uptake of I-A7 in the tumor was almost the same as those of Re-(CO)3-A7 at 24 hours postinjection. Blood clearances of Re-(CO)3-A7 were faster than that of I-A7. Conclusion: Re-labeled A7 showed high uptakes in the tumor. However, further modification of the labeling method would be necessary to improve radiochemical yields and their biodistribution.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preparation and biological evaluation of 186/188Re-HEDP as a new cocktail radiopharmaceutical for palliative treatment of osseous metastases in wild type rat

Introduction: The palliative care in patients with bone metastasis includes variety of techniques such as conventional analgesics, surgery, external beam radiotherapy, hormone therapy, chemotherapy and using bone-seeking radiopharmaceuticals. Even some of the recent works used combined methods like chemotherapy and radionuclide therapy or using radionuclide therapy as adjuvant ...

متن کامل

Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site.

OBJECTIVE Rhenium is one of the most valuable elements for internal radiotherapy because (186)Re and (188)Re have favorable physical characteristics. However, there are problems when proteins such as antibodies are used as carriers of (186/188)Re. Labeling methods that use bifunctional chelating agents such as MAG3 require the conjugation of the (186/188)Re complex to protein after radiolabelin...

متن کامل

Optimization of Natural Rhenium Irradiation Time to Produce Compositional Radiopharmaceutical

Introduction: Previously, 186Re and 188Re radioisotopes have been produced through appropriate activities, and each of them has been used for therapeutic applications. The 186Re and 188Re have unique properties, which make them proper for the treatment of  tumors in different sizes. The long-range 188Re, is suitabl...

متن کامل

Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P.

INTRODUCTION New (188)Re and (99m)Tc peptide conjugates with substance- P (SP) were prepared and biologically evaluated. The radiopharmaceuticals have been labelled with the [M≡N](2+) (M=(99m)Tc, (188)Re) core using a combination of π-donor tridentate and π-acceptor monodentate ancillary ligands. METHODS The new radiopharmaceuticals have been prepared through a two-step reaction by simultaneo...

متن کامل

A Strategy to Reduce Red Marrow Dose for Intraperitoneal Radioimmunotherapy I

The aim of this study was to determine whether shorter-lived radionuclides can reduce red marrow (RM) toxicity for i.p. radioimmunotherapy (RIT). The potential radionuclides, which included Lu-177, 1-131, Y-90, Re-186, Re-188, and Ho-166, were attached to antibody CC49. Each radiopharmaceutical was assumed to have identical in vivo pharmacokinetics. Blood and whole body retention data acquired ...

متن کامل

Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model

PURPOSE In this study, the (188)Re-labeled PEGylated nanoliposome ((188)Re-liposome) was prepared and evaluated as a therapeutic agent for glioma. MATERIALS AND METHODS The reporter cell line, F98(luc) was prepared via Lentivector expression kit system and used to set up the orthotopic glioma-bearing rat model for non-invasive bioluminescent imaging. The maximum tolerated dose applicable in F...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2017